Literature DB >> 9060702

Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody.

M Kawanishi1.   

Abstract

Tumor necrosis factor (TNF) and cytotoxic T lymphocytes, which utilize Fas to induce apoptosis in target cells, are known to play a critical role in the host defense against viral infection. In this study, the Epstein-Barr virus BHRF1 protein was stably expressed in intestine 407 cells which were susceptible to cell death mediated through both the TNF receptor and Fas. WST-1 conversion assays and acridine orange staining showed that vector-transfected control cells were killed by TNF-alpha or anti-Fas antibody in a dose-dependent manner, whereas BHRF1-expressing cells were resistant to apoptosis induced by these mediators. DNA fragmentation, a characteristic of apoptosis induced by TNF-alpha and the anti-Fas antibody, was suppressed in BHRF1-expressing cells. These results indicate that the BHRF1 protein protects cells from apoptosis mediated by the TNF receptor and Fas. The role of BHRF1 as an inhibitor of cytokine-induced apoptosis during the Epstein-Barr virus lytic cycle in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060702      PMCID: PMC191471     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.

Authors:  G R Pearson; J Luka; L Petti; J Sample; M Birkenbach; D Braun; E Kieff
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

2.  BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication.

Authors:  A Marchini; B Tomkinson; J I Cohen; E Kieff
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Authors:  B C Trauth; C Klas; A M Peters; S Matzku; P Möller; W Falk; K M Debatin; P H Krammer
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

4.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

5.  Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome.

Authors:  A J Pfitzner; E C Tsai; J L Strominger; S H Speck
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.

Authors:  J Field; J Nikawa; D Broek; B MacDonald; L Rodgers; I A Wilson; R A Lerner; M Wigler
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.

Authors:  M A Lee; J L Yates
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 9.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

10.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses.

Authors:  G H Wang; J Bertin; Y Wang; D A Martin; J Wang; K J Tomaselli; R C Armstrong; J I Cohen
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.

Authors:  L Foghsgaard; M Jäättelä
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells.

Authors:  C W Dawson; J Dawson; R Jones; K Ward; L S Young
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  ERK1/2 and the Bcl-2 Family Proteins Mcl-1, tBid, and Bim Are Involved in Inhibition of Apoptosis During Persistent Chlamydia psittaci Infection.

Authors:  Li Li; Chuan Wang; Yating Wen; Yuming Hu; Yafeng Xie; Man Xu; Mingxing Liang; Wei Liu; Liangzhuan Liu; Yimou Wu
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.

Authors:  Asuka Nanbo; Hironori Yoshiyama; Kenzo Takada
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins.

Authors:  David S Bellows; Melanie Howell; Colin Pearson; Sheila A Hazlewood; J Marie Hardwick
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 8.  The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology.

Authors:  M J Smyth; J A Trapani
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2.

Authors:  A M Flanagan; A Letai
Journal:  Cell Death Differ       Date:  2007-12-14       Impact factor: 15.828

10.  EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.

Authors:  Marc Kvansakul; Martin Rowe; Gemma L Kelly; Leah Fitzsimmons; Rachel Cartlidge; Catherine Chang; Nenad Sejic; Laura C A Galbraith; Chathura D Suraweera; Deborah Croom-Carter; Grant Dewson; Rosemary J Tierney; Andrew I Bell; Clare Shannon-Lowe; Marco J Herold; Alan B Rickinson; Peter M Colman; David C S Huang; Andreas Strasser
Journal:  Cell Death Differ       Date:  2019-10-23       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.